The European Union (EU) launched a €32 million Special Measure on Manufacturing and Access to Vaccines, Medicines and Health Technologies in Africa (MAV+) to support the development of vaccine manufacturing and the pharmaceutical industry in Ghana.
This significant investment, launched during the Ghana-EU Business Forum, aims to strengthen Ghana’s healthcare sector and increase access to quality health products.
Through this…
